Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$allr](/topic/$allr)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$allr/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$allr/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% +13%  
**1 Month**: XX% -X%  
**1-Year High**: XXX% on 2025-04-27  
**1-Year Low**: XX% on 2025-09-14  

**Most Supportive Themes**
- **FDA Fast Track Designation & Clinical Progress:** (40%) Positive sentiment around Allarity Therapeutics ($ALLR) receiving FDA Fast Track designation for Stenoparib in advanced ovarian cancer.
- **Potential for Significant Upside:** (30%) Bullish sentiment suggesting $ALLR has the potential for significant gains.
- **Positive Financial Outlook:** (15%) Mentions of positive financial aspects, such as management buybacks and strategic business alternatives.
  
**Most Critical Themes**
- **Fragile Structure and Pressure:** (15%)  Some posts indicate that the stock is under pressure.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXXXX    | XX% | XXX     | XX% | XXX      | XX% |
| YouTube | X        | X%  | X       | X%  | X        | X%  |
|         |          |     |         |     |          |     |
| Total   | XXXXX    | XX% | XXX     | XX% | XXX      | XX% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$allr

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% +13%
1 Month: XX% -X%
1-Year High: XXX% on 2025-04-27
1-Year Low: XX% on 2025-09-14

Most Supportive Themes

  • FDA Fast Track Designation & Clinical Progress: (40%) Positive sentiment around Allarity Therapeutics ($ALLR) receiving FDA Fast Track designation for Stenoparib in advanced ovarian cancer.
  • Potential for Significant Upside: (30%) Bullish sentiment suggesting $ALLR has the potential for significant gains.
  • Positive Financial Outlook: (15%) Mentions of positive financial aspects, such as management buybacks and strategic business alternatives.

Most Critical Themes

  • Fragile Structure and Pressure: (15%) Some posts indicate that the stock is under pressure.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXX XX% XXX XX% XXX XX%
YouTube X X% X X% X X%
Total XXXXX XX% XXX XX% XXX XX%
$allr Sentiment
/topic/$allr/sentiment